Fine Organic Q1 Results FY26: Q1 PAT Rose 7.04% to ₹117.10 Crore; Revenue Up 7.04% YoY

Fine Organic Q1 Results FY26: Fine Organic posted its Q1 results on 8th August 2025. The company posted robust numbers, with Q1 PAT standing at ₹117.10 crores against revenue of ₹558.38 crores. During Q1 FY26, the profit increase of the company was recorded at 3.40% YoY, and the revenue increase for the same period was 7.04%. 

Fine Organic Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

(Figures in crores)

Fine Organic Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

(Figures in crores)

Fine Organic Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

• Fine Organic clocked Q1 FY26 consolidated revenue of ₹588.38 crores vs ₹549.69 crores. 
• On the profit front, Fine Organic earned a consolidated PAT of ₹117.10 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹113.25 crore. 
• Consolidated PAT rose for the first quarter of FY26, was 3.40% YoY, and revenue increased by 7.04% YoY. 
• As per the standalone figures, the quarterly PAT of Fine Organic has decreased by 6.22%, and revenue has increased by 10.00% YoY.

Fine Organic Share Price Performance

On the opening bell of 11th August 2025, the shares of Fine Organic opened at ₹4,902.00 per share. However, the initial gains are wiped out as of now, and Fine Organic shares are trading at ₹4,875.00 per share, higher than their opening price. 

Considering the long-term performance, Fine Organic shares have yielded close to -10.24% returns in the past 1 year, and 5-year returns stand at 114.57%. Over the maximum timeframe, the Fine Organic share provided 504.05% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Fine Organic shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your research before investing in shares and other securities.

Recent Articles

Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates

Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates

Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?

Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY

Action Construction Equipment Q1 Results FY26: Q1 PAT Rises 16.08% to ₹97.72 Crore; Revenue Down 11.19% YoY

Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Connplex Cinemas IPO Allotment Status Check Online: GMP, Subscription, Price, and More

Mahendra Realtors IPO GMP & Review: Apply or Avoid?

Regaal Resources IPO GMP & Review: Apply or Avoid?

Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?